跳至主要内容
临床试验/PACTR202005906229512
PACTR202005906229512已完成未知

The effect of oral Zinc Supplementation on Glycemic Control in Type 2 Diabetic patients: a single blind randomised controlled trial.

suez canal university0 个研究点目标入组 200 人开始时间: 2020年3月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • patients with type 2 diabetes,
  • aged >18 years old,
  • attending the clinic for a routine follow-up visit,
  • on regular use of oral anti-diabetic drugs,
  • with HbAlc concentrations of 7.5-9.5%,
  • who were not enrolled in similar program in the last 6 months,
  • and not taking vitamins or mineral supplements in previous 2 months.

排除标准

  • severe or uncontrolled cardiovascular disease (defined as a cardiovascular event within the last year),
  • psychiatric disease or cognitive impairment interfering with treatment compliance,
  • pregnancy or lactating women.

研究者

相似试验

effect of zinc on diabetes | 临床试验